Nausea Vomiting Heartburn Abdominal discomfort Diarrhea Constipation Bloating Indigestion Burping Fatigue Headache Mild redness, itching, or soreness at the injection site Less Common but Important Risks Gallbladder disease or gallstones requiring removal of gallbladder Delayed stomach emptying (gastroparesis) Pancreatitis Kidney Considerations Severe dehydration related to persistent vomiting or diarrhea may increase the risk of acute kidney injury
The additional 2.5mg increment provides meaningful additional appetite suppression and metabolic effects without the full jump to the maximum dose
Participants were randomized to increasing doses of once-weekly semaglutide or placebo
Because retatrutide is newer than tirzepatide and semaglutide , the Canadian supplier market for it is less mature, and pricing varies more widely than for older peptides
"Obesity is a difficult-to-manage disease, and it's even more difficult for people living with type 2 diabetes," Jeff Emmick, MD, PhD, senior vice president, product development, Lilly, said in a statement
CAS 2805997-46-8View product Tirzepatide research FAQ